Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations

Thyroid

Volumn 21, Issue 3, 2011, Pages 221-229

  Lueblinghoff, Julia ^a   Eszlinger, Markus ^a   Jaeschke, Holger ^a   Mueller, Sandra ^a   Bircan, Rifat ^b   Gozu, Hulya ^c   Sancak, Seda ^d   Akalin, Sema ^d   Paschke, Ralf ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NAMIK KEMAL UNIVERSITY   (Turkey)

^c DR LUTFI KIRDAR KARTAL EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^d MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; THYROTROPIN RECEPTOR;

ADULT; ARTICLE; CLINICAL FEATURE; DISEASE ACTIVITY; GENE MUTATION; HUMAN; HYPERTHYROIDISM; IN VITRO STUDY; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SOMATIC MUTATION; SPORADIC MUTATION; SYSTEMATIC REVIEW; THYROID NODULE; THYROID SURGERY; THYROID WEIGHT;

CYCLIC AMP; GERM-LINE MUTATION; HUMANS; HYPERTHYROIDISM; MUTATION; RECEPTORS, THYROTROPIN; REGRESSION ANALYSIS; THYROID NODULE;

EID: 79952424398     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2010.0312     Document Type: Article

References (89)

1. Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H 2003 Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517-1525. (Pubitemid 37255037)
2. Machens A, Dralle H 2009 Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer. Thyroid 19:551-554.
3. Frank-Raue K, Machens A, Scheuba C, Niederle B, Dralle H, Raue F 2008 Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791. Clin Endocrinol (Oxf) 69:259-263. (Pubitemid 352009032)
4. Colombo-Benkmann M, Li Z, Riemann B, Hengst K, Herbst H, Keuser R, Gross U, Rondot S, Raue F, Senninger N, Putzer BM, Frank-Raue K 2008 Characterization of the RET protooncogene transmembrane domain mutation S649L associated with nonaggressive medullary thyroid carcinoma. Eur J Endocrinol 158:811-816. (Pubitemid 351837369)
5. Lueblinghoff J, Mueller S, Sontheimer J, Paschke R 2010 No correlation of TSH receptor (TSHR) Mutation's in vitro activity with the clinical course of patients with sporadic nonautoimmune hyperthyroidism. J Endocrinol Invest 33:228-233.
6. Zbuk KM, Eng C 2007 Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer 7:35-45. (Pubitemid 46020845)
7. Akcurin S, Turkkahraman D, Tysoe C, Ellard S, De LA, Vassart G, Costagliola S 2008 A family with a novel TSH receptor activating germline mutation (p. Ala485Val). Eur J Pediatr 167:1231-1237.
8. Gozu HI, Lublinghoff J, Bircan R, Paschke R 2010 Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism. Mol Cell Endocrinol 322:125-134.
9. Bircan R, Miehle K, Mladenova G, Ivanova R, Ivanova R, Sarafova A, Borissova AM, Lueblinghoff J, Paschke R 2008 Multiple relapses of hyperthyroidism after thyroid surgeries in a patient with long term follow-up of sporadic nonautoimmune hyperthyroidism. Exp Clin Endocrinol Diabetes 116:341-346. (Pubitemid 351947864)
10. Borgel K, Pohlenz J, Koch HG, Bramswig JH 2005 Long-term carbimazole treatment of neonatal nonautoimmune hyperthyroidism due to a new activating TSH receptor gene mutation (Ala428Val). Horm Res 64:203-208. (Pubitemid 41642765)
11. de Roux N, Polak M, Couet J, Leger J, Czernichow P, Milgrom E, Misrahi M 1996 A neomutation of the thyroidstimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab 81:2023-2026. (Pubitemid 26175920)
12. Esapa CT, Duprez L, Ludgate M, Mustafa MS, Kendall-Taylor P, Vassart G, Harris PE 1999 A novel thyrotropin receptor mutation in an infant with severe thyrotoxicosis. Thyroid 9:1005-1010. (Pubitemid 29521985)
13. Fuhrer D, Mix M, Wonerow P, Richter I, Willgerodt H, Paschke R 1999 Variable phenotype associated with Ser505Asnactivating thyrotropin-receptor germline mutation. Thyroid 9:757-761. (Pubitemid 29409657)
14. Gruters A, Schoneberg T, Biebermann H, Krude H, Krohn HP, Dralle H, Gudermann T 1998 Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor. J Clin Endocrinol Metab 83:1431-1436. (Pubitemid 28500998)
15. Holzapfel HP, Wonerow P, von Petrykowski W, Henschen M, Scherbaum WA, Paschke R 1997 Sporadic congenital hyperthyroidism due to a spontaneous germline mutation in the thyrotropin receptor gene. J Clin Endocrinol Metab 82:3879-3884. (Pubitemid 27509387)
16. Kopp P, Van SJ, Parma J, Duprez L, Gerber H, Joss E, Jameson JL, Dumont JE, Vassart G 1995 Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med 332:150-154.
17. Kopp P, Jameson JL, Roe TF 1997 Congenital nonautoimmune hyperthyroidism in a nonidentical twin caused by a sporadic germline mutation in the thyrotropin receptor gene. Thyroid 7:765-770. (Pubitemid 28086209)
18. Lavard L, Sehested A, Brock JB, Muller J, Perrild H, Feldt-Rasmussen U, Parma J, Vassart G 1999 Long-term follow-up of an infant with thyrotoxicosis due to germline mutation of the TSH receptor gene (Met453Thr). Horm Res 51:43-46. (Pubitemid 29154930)
19. Nishihara E, Fukata S, Hishinuma A, Kudo T, Ohye H, Ito M, Kubota S, Amino N, Kuma K, Miyauchi A 2006 Sporadic congenital hyperthyroidism due to a germline mutation in the thyrotropin receptor gene (Leu 512 Gln) in a Japanese patient. Endocr J 53:735-740. (Pubitemid 46045117)
20. Tonacchera M, Agretti P, Rosellini V, Ceccarini G, Perri A, Zampolli M, Longhi R, Larizza D, Pinchera A, Vitti P, Chiovato L 2000 Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene. Thyroid 10:859-863.
21. Chester J, Rotenstein D, Ringkananont U, Steuer G, Carlin B, Stewart L, Grasberger H, Refetoff S 2008 Congenital neonatal hyperthyroidism caused by germline mutations in the TSH receptor gene. J Pediatr Endocrinol Metab 21:479-486. (Pubitemid 351894998)
22. Watkins MG, Dejkhamron P, Huo J, Vazquez DM, Menon RK 2008 Persistent neonatal thyrotoxicosis in a neonate secondary to a rare thyroid-stimulating hormone receptor activating mutation: case report and literature review. Endocr Pract 14:479-483.
23. Bertalan R, Sallai A, Solyom J, Lotz G, Szabo I, Kovacs B, Szabo E, Patocs A, Racz K 2010 Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy. Thyroid 20:327-332.
24. Alberti L, Proverbio MC, Costagliola S, Weber G, Beck-Peccoz P, Chiumello G, Persani L 2001 A novel germline mutation in the TSH receptor gene causes non-autoimmune autosomal dominant hyperthyroidism. Eur J Endocrinol 145:249-254. (Pubitemid 32825657)
25. Arturi F, Chiefari E, Tumino S, Russo D, Squatrito S, Chazenbalk G, Persani L, Rapoport B, Filetti S 2002 Similarities and differences in the phenotype of members of an Italian family with hereditary non-autoimmune hyperthyroidism associated with an activating TSH receptor germline mutation. J Endocrinol Invest 25:696-701.
26. Biebermann H, Schoneberg T, Hess C, Germak J, Gudermann T, Gruters A 2001 The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 86:4429-4433. (Pubitemid 32848570)
27. Claus M, Maier J, Paschke R, Kujat C, Stumvoll M, Fuhrer D 2005 Novel thyrotropin receptor germline mutation (Ile568-Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism. Thyroid 15:1089-1094. (Pubitemid 41475722)
28. Duprez L, Parma J, Van SJ, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J, Vassart G 1994 Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet 7:396-401. (Pubitemid 24204416)
29. Ferrara AM, Capalbo D, Rossi G, Capuano S, Del PG, Esposito V, Montesano G, Zampella E, Fenzi G, Salerno M, Macchia PE 2007 A new case of familial nonautoimmune hyperthyroidism caused by the M463V mutation in the TSH receptor with anticipation of the disease across generations: a possible role of iodine supplementation. Thyroid 17:677-680. (Pubitemid 47311558)
30. Fuhrer D, Wonerow P, Willgerodt H, Paschke R 1997 Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82:4234-4238. (Pubitemid 27525546)
31. Fuhrer D, Warner J, Sequeira M, Paschke R, Gregory J, Ludgate M 2000 Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism. Thyroid 10:1035-1041. (Pubitemid 32095071)
32. Horton GL, Scazziga BR 1987 Hereditary hyperthyroidism with diffuse non autoimmune hyperactivity due to autonomy of function and growth. Ann Endocrinol (Paris) 48:92.
33. Karges B, Krause G, Homoki J, Debatin KM, de RN, Karges W 2005 TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5. J Endocrinol 186:377-385. (Pubitemid 41167406)
34. Khoo DH, Parma J, Rajasoorya C, Ho SC, Vassart G 1999 A germline mutation of the thyrotropin receptor gene associated with thyrotoxicosis and mitral valve prolapse in a Chinese family. J Clin Endocrinol Metab 84:1459-1462. (Pubitemid 30644415)
35. Lee YS, Poh L, Loke KY 2002 An activating mutation of the thyrotropin receptor gene in hereditary non-autoimmune hyperthyroidism. J Pediatr Endocrinol Metab 15:211-215. (Pubitemid 34704797)
36. Liu Z, Sun Y, Dong Q, He M, Cheng CH, Fan F 2008 A novel TSHR gene mutation (Ile691Phe) in a Chinese family causing autosomal dominant non-autoimmune hyperthyroidism. J Hum Genet 53:475-478.
37. Nwosu BU, Gourgiotis L, Gershengorn MC, Neumann S 2006 A novel activating mutation in transmembrane helix 6 of the thyrotropin receptor as cause of hereditary nonautoimmune hyperthyroidism. Thyroid 16:505-512.
38. Pohlenz J, Pfarr N, Kruger S, Hesse V 2006 Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R). Acta Paediatr 95:1685-1687. (Pubitemid 44863829)
39. Ringkananont U, Van DJ, Montanelli L, Ugrasbul F, Yu YM, Weiss RE, Refetoff S, Grasberger H 2006 Repulsive separation of the cytoplasmic ends of transmembrane helices 3 and 6 is linked to receptor activation in a novel thyrotropin receptor mutant (M626I). Mol Endocrinol 20:893-903.
40. Schwab KO, Gerlich M, Broecker M, Sohlemann P, Derwahl M, Lohse MJ 1997 Constitutively active germline mutation of the thyrotropin receptor gene as a cause of congenital hyperthyroidism. J Pediatr 131:899-904. (Pubitemid 28027617)
41. Thomas JS, Leclere J, Hartemann P, Duheille J, Orgiazzi J, Petersen M, Janot C, Guedenet JC 1982 Familial hyperthyroidism without evidence of autoimmunity. Acta Endocrinol (Cph) 100:512-518. (Pubitemid 12089226)
42. Tonacchera M, Van SJ, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J 1996 Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia. J Clin Endocrinol Metab 81:547-554. (Pubitemid 26055662)
43. Vaidya B, Campbell V, Tripp JH, Spyer G, Hattersley AT, Ellard S 2004 Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation. Clin Endocrinol (Oxf) 60:711-718. (Pubitemid 38788079)
44. Elgadi A, Arvidsson CG, Janson A, Marcus C, Costagliola S, Norgren S 2005 Autosomal-dominant non-autoimmune hyperthyroidism presenting with neuromuscular symptoms. Acta Paediatr 94:1145-1148. (Pubitemid 41169669)
45. Supornsilchai V, Sahakitrungruang T, Wongjitrat N, Wacharasindhu S, Suphapeetiporn K, Shotelersuk V 2009 Expanding clinical spectrum of non-autoimmune hyperthyroidism due to an activating germline mutation, p. M453T, in the thyrotropin receptor gene. Clin Endocrinol (Oxf) 70:623-628.
46. Nishihara E, Nagayama Y, Amino N, Hishinuma A, Takano T, Yoshida H, Kubota S, Fukata S, Kuma K, Miyauchi A 2007 A novel thyrotropin receptor germline mutation (Asp617Tyr) causing hereditary hyperthyroidism. Endocr J 54:927-934. (Pubitemid 351346775)
47. Jaeschke H, Eszlinger M, Lueblinghoff J, Coslovsky R, Paschke R 2010 Prolonged inappropriate TSH suppression during hypothyroidism after thyroid ablation in a patient with non autoimmune familial hyperthyroidism due to a M626I TSHR germline mutation. Poster discussion presented at the 14th International Thyroid Conference, Paris, France, September 11-16.
48. Arturi F, Capula C, Chiefari E, Filetti S, Russo D 1998 Thyroid hyperfunctioning adenomas with and without Gsp/TSH receptor mutations show similar clinical features. Exp Clin Endocrinol Diabetes 106:234-236. (Pubitemid 28356617)
49. Hebrant A, Van SJ, Roger PP, Patey M, Klein M, Bournaud C, Savagner F, Leclere J, Dumont JE, van Staveren WC, Maenhaut C 2009 Thyroid gene expression in familial nonautoimmune hyperthyroidism shows common characteristics with hyperfunctioning autonomous adenomas. J Clin Endocrinol Metab 94:2602-2609.
50. Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D 1993 Long-term follow-up in patients with autonomous thyroid adenoma. Acta Endocrinol (Cph) 128:51-55. (Pubitemid 23055241)
51. Arseven OK, Wilkes WP, Jameson JL, Kopp P 2000 Substitutions of tyrosine 601 in the human thyrotropin receptor result in increase or loss of basal activation of the cyclic adenosine monophosphate pathway and disrupt coupling to Gq/11. Thyroid 10:3-10.
52. Derwahl M, Hamacher C, Russo D, Broecker M, Manole D, Schatz H, Kopp P, Filetti S 1996 Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J Clin Endocrinol Metab 81:1898-1904.
53. Duprez L, Parma J, Costagliola S, Hermans J, Van SJ, Dumont JE, Vassart G 1997 Constitutive activation of the TSH receptor by spontaneous mutations affecting the N-terminal extracellular domain. FEBS Lett 409:469-474. (Pubitemid 27285907)
54. Duprez L, Hermans J, Van SJ, Dumont JE, Vassart G, Parma J 1997 Two autonomous nodules of a patient with multinodular goiter harbor different activating mutations of the thyrotropin receptor gene. J Clin Endocrinol Metab 82:306-308. (Pubitemid 27021316)
55. Fuhrer D, Holzapfel HP, Wonerow P, Scherbaum WA, Paschke R 1997 Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules. J Clin Endocrinol Metab 82:3885-3891. (Pubitemid 27509388)
56. Georgopoulos NA, Sykiotis GP, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Papavassiliou AG, Vagenakis AG 2003 Autonomously functioning thyroid nodules in a former iodine-deficient area commonly harbor gain-of-function mutations in the thyrotropin signaling pathway. Eur J Endocrinol 149:287-292. (Pubitemid 37304698)
57. Gozu H, Avsar M, Bircan R, Sahin S, Deyneli O, Cirakoglu B, Akalin S 2005 Mutations in the thyrotropin receptor signal transduction pathway in the hyperfunctioning thyroid nodules from multinodular goiters: a study in the Turkish population. Endocr J 52:577-585. (Pubitemid 41609047)
58. Holzapfel HP, Fuhrer D, Wonerow P, Weinland G, Scherbaum WA, Paschke R 1997 Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters. J Clin Endocrinol Metab 82:4229-4233. (Pubitemid 27525545)
59. Kopp P, Muirhead S, Jourdain N, Gu WX, Jameson JL, Rodd C 1997 Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281->isoleucine) in the extracellular domain of the thyrotropin receptor. J Clin Invest 100:1634-1639. (Pubitemid 27425791)
60. Kosugi S, Hai N, Okamoto H, Sugawa H, Mori T 2000 A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. Eur J Endocrinol 143:471-477.
61. Nogueira CR, Kopp P, Arseven OK, Santos CL, Jameson JL, Medeiros-Neto G 1999 Thyrotropin receptor mutations in hyperfunctioning thyroid adenomas from Brazil. Thyroid 9:1063-1068.
62. Parma J, Van SJ, Swillens S, Tonacchera M, Dumont J, Vassart G 1995 Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3', 5'-monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrinol 9:725-733.
63. Parma J, Duprez L, Van SJ, Hermans J, Rocmans P, Van VG, Costagliola S, Rodien P, Dumont JE, Vassart G 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gs alpha genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 82:2695-2701. (Pubitemid 27337896)
64. Paschke R, Tonacchera M, Van SJ, Parma J, Vassart G 1994 Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J Clin Endocrinol Metab 79:1785-1789.
65. Porcellini A, Ciullo I, Laviola L, Amabile G, Fenzi G, Avvedimento VE 1994 Novel mutations of thyrotropin receptor gene in thyroid hyperfunctioning adenomas. Rapid identification by fine needle aspiration biopsy. J Clin Endocrinol Metab 79:657-661. (Pubitemid 24256570)
66. Russo D, Arturi F, Wicker R, Chazenbalk GD, Schlumberger M, DuVillard JA, Caillou B, Monier R, Rapoport B, Filetti S 1995 Genetic alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 80:1347-1351.
67. Sykiotis GP, Sgourou A, Papachatzopoulou A, Markou KB, Kyriazopoulou V, Papavassiliou AG, Vagenakis AG, Georgopoulos NA 2002 A somatic mutation in the thyrotropin receptor gene in a patient with an autonomous nodule within a multinodular goiter. Hormones (Athens) 1:42-46.
68. Tassi V, Di CA, Porcellini A, Papini E, Cisternino C, Crescenzi A, Scillitani A, Pizzuti A, Ratti A, Trischitta V, Avvedimento VE, Fenzi G, De Filippis V 1999 Screening of thyrotropin receptor mutations by fine-needle aspiration biopsy in autonomous functioning thyroid nodules in multinodular goiters. Thyroid 9:353-357. (Pubitemid 29206845)
69. Tonacchera M, Vitti P, Agretti P, Giulianetti B, Mazzi B, Cavaliere R, Ceccarini G, Fiore E, Viacava P, Naccarato A, Pinchera A, Chiovato L 1998 Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. Thyroid 8:559-564. (Pubitemid 28354906)
70. Tonacchera M, Chiovato L, Pinchera A, Agretti P, Fiore E, Cetani F, Rocchi R, Viacava P, Miccoli P, Vitti P 1998 Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma. J Clin Endocrinol Metab 83:492-498. (Pubitemid 28496528)
71. Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A, Viacava P, Naccarato AG, Miccoli P, Pinchera A, Vitti P 2000 Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J Clin Endocrinol Metab 85:2270-2274. (Pubitemid 32269254)
72. Vanvooren V, Uchino S, Duprez L, Costa MJ, Vandekerckhove J, Parma J, Vassart G, Dumont JE, Van SJ, Noguchi S 2002 Oncogenic mutations in the thyrotropin receptor of autonomously functioning thyroid nodules in the Japanese population. Eur J Endocrinol 147:287-291.
73. Palos-Paz F, Perez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimeno C, Barreiro-Morandeira F, Lado-Abeal J, Araujo VD, Argueso R, Barca O, Botana M, Cabezas-Agricola JM, Catalina P, Dominguez GL, Fernandez T, Mato A, Nuno A, Penin M, Victoria B, Paloz-Paz F, Perrez-Guerra O, Cameselle-Teijeiro J, Rueda-Chimio JC, Barreio-Morandeira F 2008 Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain. Eur J Endocrinol 159:623-631.
74. Krohn K, Sancak S, Jaeschke H, Semiha Sen L, Gulluoglu BM, Tanav Eran F, Sever Z, Sema Akalin N, Paschke R., Eszlinger M 2008 High prevalence of TSHR/Gsa-mutationnegative clonal toxic thyroid nodules in a turkish cohort. Hormones Suppl 1:42.
75. Kosugi S, Akamizu T, Takai O, Prabhakar BS, Kohn LD 1991 The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies. Thyroid 1:321-330.
76. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Fuhrer D, Paschke R 2001 Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 78:684-691. (Pubitemid 32200314)
77. Jaeschke H, Kleinau G, Sontheimer J, Mueller S, Krause G, Paschke R 2008 Preferences of transmembrane helices for cooperative amplification of G (alpha) s and G (alpha) q signaling of the thyrotropin receptor. Cell Mol Life Sci 65:4028-4038.
78. Gozu HI, Mueller S, Bircan R, Krohn K, Ekinci G, Yavuzer D, Sargin H, Sargin M, Ones T, Gezen C, Orbay E, Cirakoglu B, Paschke R 2008 A new silent germline mutation of the TSH receptor: coexpression ina hyperthyroid family member with a second activating somatic mutation. Thyroid 18:499-508. (Pubitemid 351667836)
79. Zhang ML, Sugawa H, Kosugi S, Mori T 1995 Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain. Biochem Biophys Res Comm 211:205-210.
80. Jaeschke H, Neumann S, Kleinau G, Mueller S, Claus M, Krause G, Paschke R 2006 An aromatic environment in the vicinity of serine 281 is a structural requirement for thyrotropin receptor function. Endocrinology 147:1753-1760.
81. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S 2002 Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16:736-746. (Pubitemid 34297743)
82. Kleinau G, Jaeschke H, Mueller S, Raaka BM, Neumann S, Paschke R, Krause G 2008 Evidence for cooperative signal triggering at the extracellular loops of the TSH receptor. FASEB J 22:2798-2808.
83. Mueller S, Gozu HI, Bircan R, Jaeschke H, Eszlinger M, Lueblinghoff J, Krohn K, Paschke R 2009 Cases of borderline in vitro constitutive thyrotropin receptor activity: how to decide whether a thyrotropin receptor mutation is constitutively active or not? Thyroid 19:765-773.
84. Gozu HI, Bircan R, Krohn K, Muller S, Vural S, Gezen C, Sargin H, Yavuzer D, Sargin M, Cirakoglu B, Paschke R 2006 Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur J Endocrinol 155:535-545. (Pubitemid 44608426)
85. Kleinau G, Jaeschke H, Mueller S, Worth CL, Paschke R, Krause G 2008 Molecular and structural effects of inverse agonistic mutations on signaling of the thyrotropin receptor-a basally active GPCR. Cell Mol Life Sci 65:3664-3676.
86. Russo D, Arturi F, Suarez HG, Schlumberger M, du Villard JA, Crocetti U, Filetti S 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 81:1548-1551. (Pubitemid 26118590)
87. Krohn K, Fuhrer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R 2005 Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504-524. (Pubitemid 41014264)
88. Kursawe R, Paschke R 2007 Modulation of TSHR signaling by posttranslational modifications. Trends Endocrinol Metab 18:199-207. (Pubitemid 46962302)
89. Brauer VF, Eder P, Miehle K, Wiesner TD, Hasenclever H, Paschke R 2005 Interobserver variation for ultrasound determination of thyroid nodule volumes. Thyroid 15:1169-1175. (Pubitemid 41720724)